UK: Drugs firms ‘creating ills for every pill / US ‘Bioshield’ Drug-Patent Plan Draws Fire Mon, 04 Apr 2005 Following the public revelations about the concealed safety hazards of antidepressant drugs whose risks of violence, drug dependency, and suicide, were hidden from physicians and the public, a committee of Parliament…
Paxil Protest at GSK US headquarters Sept. 26–Sept. 28 Sun, 18 Sep 2005 Families and victims who have suffered harm from SSRI antidepressants are heading for Philadelphia from the US and Canada for a “Paxil Protest.” Date: September 26 through Sept. 28. Place: GlaxoSmithKline US headquarters in Philadelphia The organizer of this event is…
Petition FDA to Investigate if SSRI Induced School Shootings Fri, 25 Mar 2005 The Minnesota shooting rampage by 16-year old Jeff Weise, prompted the parent organization, Ablechild.org, to petition the FDA to conduct “a full investigation into the possible SSRI induced school shootings.” “It took 15 years for the FDA…
Pfizer Admits Guilt in Promotion of Neurontin–Agrees to Pay $430 Million Sun, 16 May 2004 A lawsuit initiated by Dr. David Franklin, a whistleblower, has been settled: Pfizer pleaded guilty to criminal fraud in the promotion of Neurontin, and agreed to pay $430 million. This case is but an example…
Pfizer Must Hand Over Documents in Pitman Case Sat, 4 Dec 2004 A federal judge in Charlotte North Carolina rejected Pfizer’s arguments and ordered the company to hand over the concealed documents sought by defense counsels in the criminal case against Christopher Pitman, a teenager who, at the age of…
Schizophrenia Drug Implants May Qualify as Medical Torture Sun, 17 Nov 2002 In some patients, antipsychotic drugs induce excruciating, intolerable side-effects. In some people these drugs’ toxic action has caused severe liver, heart, and kidney damage, as well as dangerously high blood pressure– some patients have died as a result…
British Medical Journal critized for promoting drug cocktail ignoring risks Mon, 14 Jul 2003 The push toward adopting a radical cholesterol lowering strategy, including the use of statin drugs was given a shot in the arm when the British Medical Journal (BMJ) published an article– endorsed by its editor–promoting the…
FDA Statement Regarding Anti-Depressant Paxil for Children Thu, 19 Jun 2003 A knowledgeable critic suggested that the FDA was pushed into action, but the action (Statement below) is weak. Evidence about the risks of antidepressants such as Paxil (Seroxat) have been linked to severe withdrawal symptoms which are a sign…
A Special Article By Curt D. Furberg, MD, PhD; Arthur A. Levin, MPH; Peter A. Gross, MD; Robyn S. Shapiro, JD; Brian L. Strom, MD, MPH
The battle lines were drawn between those who recognize the corrosive effect that the pharmaceutical industry is having on the safety and integrity of medicine and medical research, and the powerful stakeholders–the pharmaceutical-academic industrial complex.
Dr. Sanghavi provides us with a statistical reality-check by which to gauge for ourselves whether or not we should–or need not–take a octor’s advice about starting a medical treatment for a speculated risk–rather than evidence of illness.
A report by the Institute of Medicine is sharply critical of FDA’s drug safety monitoring system: "The report’s conclusions are striking and often damning – particularly when discussing the agency’s Center for Drug Evaluation and Research, known as C.D.E.R."
